Online citations, reference lists, and bibliographies.
← Back to Search

Otros Tumores Torácicos: Mesotelioma, Timoma Y Tumores Germinales Mediastínicos

F. Expósito, F. Expósito, J. L. González, J. L. González, A. L. Lete, A. L. Lete, M. Á. Soto, M. Á. Soto
Published 2009 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Resumen El mesotelioma es un tumor de crecimiento inicial lento que surge fundamentalmente a partir de la pleura y el peritoneo. El asbesto esta claramente relacionado en su etiologia, siendo el principal implicado en su desarrollo. La neumonectomia extrapleural en pacientes seleccionados es el tratamiento de eleccion. No obstante, la mayoria de los pacientes no son candidatos a cirugia, y su mejor opcion es la poliquimioterapia paliativa. Los timomas son neoplasias del mediastino anterior poco comunes. Los carcinomas timicos son aun menos frecuentes, pero mas agresivos. El tratamiento de eleccion es quirurgico, con reseccion en bloque de la tumoracion. El mediastino es la localizacion extragonadal mas frecuente de los tumores germinales. Se originan con mayor frecuencia en la tercera decada de la vida, con mayor incidencia en hombres que en mujeres. La diferenciacion histologica entre teratomas, seminomas puros y tumores no seminomatosos tiene gran implicacion en el pronostico y en el tratamiento.
This paper references
10.1200/JCO.2001.19.3.682
Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum.
J. Vuky (2001)
10.1016/S0936-6555(05)80582-5
The role of palliative radiotherapy in malignant mesothelioma.
D. Bissett (1991)
10.1378/CHEST.103.4_SUPPLEMENT.377S
Extrapleural pneumonectomy in the setting of a multimodality approach to malignant mesothelioma.
D. Sugarbaker (1993)
10.1016/S0022-5223(19)36577-8
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.
V. Rusch (1991)
10.1200/JCO.1996.14.3.814
Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
G. Giaccone (1996)
10.1016/S0003-4975(99)01472-1
Intensive chemotherapy and radical resections for primary nonseminomatous mediastinal germ cell tumors.
G. Walsh (2000)
10.1002/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V
Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 1: Diagnosis
C. Boutin (1993)
10.1002/cncr.10226
The World Health Organization histologic classification system reflects the oncologic behavior of thymoma
M. Okumura (2002)
10.1093/ANNONC/MDH356
The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma.
E. Andreopoulou (2004)
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
G. Mead (1997)
10.1067/MTC.2003.133
Aggressive multimodality treatment of invasive thymic carcinoma.
M. Greene (2003)
10.1200/JCO.2008.17.5604
Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
M. D. de Perrot (2009)
10.1097/00000658-199609000-00005
Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.
D. Sugarbaker (1996)
10.1200/JCO.2003.11.136
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
10.1002/1097-0142(19910415)67:8<2033::AID-CNCR2820670804>3.0.CO;2-8
Activity of intrapleural recombinant gamma‐interferon in malignant mesothelioma
C. Boutin (1991)
10.1378/CHEST.108.4.1122
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
V. Rusch (1995)
10.1023/A:1008225129682
Mediastinal non-seminomatous germ cell tumours (MNSGCT) treated with cisplatin-based combination chemotherapy.
M. Hidalgo (1997)
10.1200/JCO.1994.12.6.1156
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
V. Rusch (1994)
10.1016/j.athoracsur.2009.05.022
Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma.
D. Rice (2009)
10.1002/1097-0142(19930415)71:8<2631::AID-CNCR2820710831>3.0.CO;2-G
Alternating combination chemotherapy in patients with extragonadal germ cell tumors a southwest oncology group study
R. Bukowski (1993)
10.1200/JCO.1993.11.8.1559
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.
A. Chahinian (1993)
10.1097/00000421-198602000-00020
Cancer : Principles and Practice of Oncology
V. Devita (1982)
10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R
Follow‐up study of thymomas with special reference to their clinical stages
A. Masaoka (1981)
10.1016/S0049-0172(98)80039-5
Malignant thymoma associated with autoimmune diseases: a retrospective study and review of the literature.
Y. Levy (1998)
10.1093/annonc/mdp516
Outcome following resection for patients with primary mediastinal nonseminomatous germ-cell tumors and rising serum tumor markers post-chemotherapy.
S. Radaideh (2010)
10.1007/978-3-642-60157-6
Histological Typing of Tumours of the Thymus
J. Rosai (1999)
10.1016/j.athoracsur.2007.09.020
A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.
K. Kesler (2008)
10.1002/cncr.10588
Treatment and prognosis of thymic carcinoma
K. Ogawa (2002)
10.1200/JCO.1996.14.3.1007
Chemotherapy in malignant pleural mesothelioma. A review.
S. T. Ong (1996)
10.1002/cncr.10665
New WHO histologic classification predicts prognosis of thymic epithelial tumors
G. Chen (2002)
10.1016/j.jtcvs.2009.02.046
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
T. R. Tilleman (2009)
10.1002/1097-0142(20010401)91:7<1394::AID-CNCR1144>3.0.CO;2-Y
Extragonadal seminoma
C. Bokemeyer (2001)



Semantic Scholar Logo Some data provided by SemanticScholar